Yahoo Web Search

  1. Ads
    related to "multiple sclerosis"
  1. Yahoo Finance Results

  2. This project will explore standardization of PRO measures between "patient-powered" research initiatives and will enable improved health, healthcare and quality of life for people affected by ...

  3. 4 Things Celgene's CEO Just Said That You'll Really Want to Know

    Motley Fool via Yahoo FinanceJun 01 12:17 PM

    Celgene (NASDAQ: CELG) seems to have become the Rodney Dangerfield of biotech stocks. With a lot of negativity still surrounding the company, CEO Mark Alles spoke on Wednesday at the Bernstein ...

  4. Here's Why Acorda Therapeutics Rose as Much as 30.3% Today

    Motley Fool via Yahoo FinanceJun 08 17:02 PM

    District Court to invalidate four of the company's patents for its multiple sclerosis drug Ampyra, which is the top revenue generator for the business and is expected to deliver ...

  5. 3 Top Healthcare Stocks to Buy Right Now

    Motley Fool via Yahoo FinanceJun 01 12:44 PM

    Sean Williams (Celgene): Even though I've absolutely beaten the door down on Celgene in May, it's the top healthcare stock to buy in my mind right now -- and also a company I added to my portfolio ...

  6. It has been about a month since the last earnings report for Celgene Corporation CELG. Celgene reported encouraging first-quarter 2018 results wherein both earnings and sales topped expectations ...

  7. Biotech ETFs Are the Best Way to Play the Recovering Sector

    InvestorPlace via Yahoo FinanceMay 30 15:43 PM

    The summer of 2015 marked the end of the glory years in the biotechnology sector. Some well-known, large-cap names — such as AbbVie Inc (NYSE:ABBV) and Pfizer Inc. (NYSE:PFE) — are currently ...

  8. More than 5,000 Patients Enrolled in Corrona® Psoriasis Registry

    PR Newswire via Yahoo FinanceJun 05 12:00 PM

    Created to help researchers compare the safety and effectiveness of approved psoriasis therapies, the Corrona Psoriasis Registry is the largest, independent North American registry of psoriasis ...

  9. -stabilized multiple sclerosis franchise, with potentially volatile Spinraza sales. Kulkarni considers Biogen’s non-Alzheimer’s portfolio and long-term biosimilar opportunity undervalued ...

  10. If Medicare were to utilize one-size-fits-all value assessments like the Institute for Clinical and Economic Review's (ICER) framework as the basis for coverage, 62 to 93 percent of patients ...

  11. 5 Best-Selling Orphan Drugs in the U.S.

    Motley Fool via Yahoo FinanceMay 30 13:17 PM

    Orphan drugs target rare diseases and disorders that typically affect fewer than 200,000 people in the U.S. But while relatively few patients benefit from orphan drugs, the market size is very ...

  1. Ads
    related to "multiple sclerosis"